Literature DB >> 30160498

The Multidimensional Emotional Disorder Inventory (MEDI): Assessing transdiagnostic dimensions to validate a profile approach to emotional disorder classification.

Anthony J Rosellini1, Timothy A Brown1.   

Abstract

There has been limited progress evaluating the validity of dimensional approaches to emotional disorder classification. This has occurred in part because of a lack of standardized assessment tools developed with the specific intent of studying dimensional classification. The goal of the current study was to develop and validate the Multidimensional Emotional Disorder Inventory (MEDI) to efficiently assess nine empirically supported transdiagnostic dimensions proposed in the Brown and Barlow (2009) profile approach to emotional disorder classification: neurotic temperament, positive temperament, depression, autonomic arousal, somatic anxiety, social anxiety, intrusive cognitions, traumatic reexperiencing, and avoidance. The MEDI factor structure, reliability, and convergent/discriminant validity was evaluated in outpatients with emotional disorders (pilot sample = 227; validation sample = 780). The final 9-factor solution fit the data well. Intercorrelations among MEDI factors were consistent with previous research, and all MEDI dimensions had acceptable reliability. Correlations with common self-report questionnaires and DSM-5 diagnoses supported the convergent/discriminant validity of all nine MEDI dimensions. Collectively, these results support the use of 49-item MEDI in clinical research samples. The MEDI should be used in future research to evaluate the validity of the Brown and Barlow (2009) approach to emotional disorder classification. Because it provides an efficient assessment of several well-established emotional disorder traits and phenotypes, the MEDI also may have utility for general research or clinical purposes. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 30160498      PMCID: PMC6312761          DOI: 10.1037/pas0000649

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  5 in total

1.  Implementation, efficacy and cost effectiveness of the unified protocol in a blended format for the transdiagnostic treatment of emotional disorders: a study protocol for a multicentre, randomised, superiority controlled trial in the Spanish National Health System.

Authors:  J Osma; Laura Martínez-García; Óscar Peris-Baquero; María Vicenta Navarro-Haro; Alberto González-Pérez; Carlos Suso-Ribera
Journal:  BMJ Open       Date:  2021-12-31       Impact factor: 2.692

2.  Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial.

Authors:  Kou Yan; Mohammad Hassan Yusufi; Nabi Nazari
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

3.  Application of the unified protocol for the transdiagnostic treatment of comorbid emotional disorders in patients with ultra-high risk of developing psychosis: A randomized trial study protocol.

Authors:  Trinidad Peláez; Raquel López-Carrillero; Marta Ferrer-Quintero; Susana Ochoa; Jorge Osma
Journal:  Front Psychol       Date:  2022-09-01

4.  Dealing with complexity and comorbidity: Opportunity for transdiagnostic treatment for PTSD.

Authors:  Cassidy A Gutner; Candice Presseau
Journal:  Curr Treat Options Psychiatry       Date:  2019-05-09

5.  Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods.

Authors:  Todd J Farchione; Hayley E Fitzgerald; Andrew Curreri; Amy C Janes; Matthew W Gallagher; Sophia Sbi; Elizabeth H Eustis; David H Barlow
Journal:  Contemp Clin Trials       Date:  2021-07-17       Impact factor: 2.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.